Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies. [electronic resource]
Producer: 19950907Description: 367-75 p. digitalISSN:- 0340-7004
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Anti-Idiotypic -- biosynthesis
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Neoplasm -- biosynthesis
- Colorectal Neoplasms -- immunology
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- pharmacology
- Humans
- Immunoglobulin Isotypes -- biosynthesis
- Immunotherapy
- Immunotoxins -- adverse effects
- Male
- Middle Aged
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.